LILLYS TIRZEPATIDE SUPERIOR TO WEGOVY IN HEAD-TO-HEAD TRIAL SHOWING AN AVERAGE WEIGHT LOSS OF 20.2 percent VS. 13.7
| JEPCX Fund | USD 14.83 0.02 0.13% |
Slightly above 62% of Jpmorgan Research's investor base is looking to short. The analysis of overall sentiment of trading Jpmorgan Research Equity mutual fund suggests that many investors are alarmed at this time. Jpmorgan Research's investing sentiment can be driven by a variety of factors including economic data, Jpmorgan Research's earnings reports, geopolitical events, and overall market trends.
Jpmorgan |
Eli Lilly Canada today announced topline results from the SURMOUNT-5 Phase 3b open-label randomized clinical trial. Tirzepatide provided a 47 percent greater relative weight loss compared to Wegovy . On average, tirzepatide led to a superior weight loss of 20.2 percent compared to 13.7 percent with Wegovy.i At 72 weeks, tirzepatide was superior to Wegovy on both the primary endpoint and all five key secondary endpoints in this trial of adults living with obesity or overweight with at least one weight-r
Read at finance.yahoo.com
 |
Jpmorgan Research Fundamental Analysis
We analyze Jpmorgan Research's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jpmorgan Research using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jpmorgan Research based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Position Weight
Cash Position Weight Comparative Analysis
Jpmorgan Research is currently under evaluation in cash position weight among similar funds. Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Jpmorgan Research Equity Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Jpmorgan Research mutual fund to make a market-neutral strategy. Peer analysis of Jpmorgan Research could also be used in its relative valuation, which is a method of valuing Jpmorgan Research by comparing valuation metrics with similar companies.
Peers
Jpmorgan Research Related Equities
| MMDEX | Praxis Growth | 1.62 | ||||
| LANIX | Qs Growth | 0.64 | ||||
| CIPMX | Champlain Mid | 0.42 | ||||
| PRNHX | T Rowe | 0.27 | ||||
| HSUAX | Rational Defensive | 0.05 | ||||
| PQUAX | Pace Smallmedium | 0.64 |
Other Information on Investing in Jpmorgan Mutual Fund
Jpmorgan Research financial ratios help investors to determine whether Jpmorgan Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jpmorgan with respect to the benefits of owning Jpmorgan Research security.
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |